Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2025 10:23 ET | Source: Research and Markets

Chronic Heart Failure Market Analysis and Forecast, 2025-2035, Featuring AstraZeneca, Bristol Myers Squibb, Cytokinetics, Bayer, Eli Lilly and Other Leading Players

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Chronic Heart Failure Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering....
September 22, 2025 06:20 ET | Source: CELLPROTHERA

CellProthera annonce la publication de ses résultats de phase I/IIb sur la sécurité et la faisabilité des ProtheraCytes® chez des patients souffrant d'insuffisance cardiaque sévère après un infarctus du myocarde.

La publication du JACC-Heart Failure souligne la haute qualité de l'expansion cellulaire, la bonne tolérance, le risque procédural gérable et les signes précoces encourageants d'effets fonctionnels. ...
September 22, 2025 06:20 ET | Source: CELLPROTHERA

CellProthera announces peer-reviewed publication of its Phase I/IIb results on safety and feasibility of ProtheraCytes® in patients with severe heart failure post-myocardial Infarction

JACC-Heart Failure publication highlights high-quality cell expansion, good tolerability, manageable procedural risk and encouraging early signals of functional effects. Mulhouse, France – [DATE] –...
November 04, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification

CytoSorbents submits DrugSorb-ATR Medical Device License Application to Health Canada following MDSAP Certification. Expects regulatory decision in 2025
April 09, 2024 08:00 ET | Source: UMeWorld Limited

UMeWorld to Debut the World's First & Only Weight Loss Cooking Oil in the US

MIAMI, April 09, 2024 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is excited to announce that the company has secured an exclusive license to use proprietary enzymatic technologies to...
March 01, 2024 05:49 ET | Source: Powerful Medical

Powerful Medical Secures €7.5M in Funding from European Innovation Council to Revolutionize Heart Attack Diagnostics with AI

Powerful Medical Secures €7.5M in Funding from European Innovation Council to Revolutionize Heart Attack Diagnostics with AI
December 06, 2023 22:04 ET | Source: Camfil USA Air Filters

New Study Links Heart Attack Deaths to Particulate Matter Exposure, Camfil Air Quality Professionals Explain

Riverdale, Dec. 06, 2023 (GLOBE NEWSWIRE) -- A study published earlier this year found that the risk of death from a heart attack could potentially double when both temperatures and ambient levels...
November 22, 2023 07:18 ET | Source: Research and Markets

Thrombosis And Hemostasis Biomarkers Research Report 2023: Point-of-Care Analyzers Gain Traction - Global Forecast to 2030

Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Thrombosis And Hemostasis Biomarkers Market Size, Share & Trends Analysis Report By Product (Analyzers, Reagents & Consumables), By Test...
November 20, 2023 07:04 ET | Source: Powerful Medical

PMcardio Is The First Certified Solution To Outperform Doctors in Heart Attack Detection With AI

PMcardio's Queen of Hearts is the first certified solution to outperform doctors in heart attack detection from the ECG using artificial intelligence.
March 07, 2023 14:30 ET | Source: Transparency Market Research

Inotropic Agents Market Value to Surpass US$ 5.1 Bn by 2031: TMR Study

Wilmington, Delaware, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – As per a TMR study, the Inotropic Agents Market was valued at US$ 1.9 Bn in 2022 and is...